breast cancer

color-enhanced cross section of tumor tissue
January 16, 2017

Softening tumor tissue could aid cancer treatments

Tumors cause the intracellular material surrounding them to stiffen. Softening this protective layer could make existing cancer treatments more effective, according to new research.

By VUMC News and Communications
November 18, 2016

Targeting the “un-targetable”

A novel drug that targets the protein RSK blocked aggressive breast cancers from metastasizing in an animal model.

By VUMC News and Communications
September 29, 2016

BMI genotype and breast cancer risk

For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults.

By Paul Govern
September 22, 2016

National Lymphedema Network honors VUMC research efforts

Lymphedema research conducted at Vanderbilt University Medical Center (VUMC) to better understand patient risk for this chronic condition and treatment responses received recognition at an international conference.

By Tom Wilemon
September 9, 2016

In search of new cancer targets

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

By Leigh MacMillan
August 26, 2016

New breast cancer driver

Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

By Leigh MacMillan
July 20, 2016

Breast cancer: finding the smoking gun

A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes.
By Bill Snyder
July 6, 2016

VICC researchers to study reasons for high breast cancer incidence and mortality rates among African-American women

A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.
By VUMC News and Communications
April 21, 2016

Study explores how some breast cancers resist treatment

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.
By VUMC News and Communications
April 14, 2016

Switching breast cancer off

Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.
By Marilyn Holt
February 11, 2016

Annual Pink Out women’s basketball game set for Feb. 14

Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer.
By VUMC News and Communications
January 7, 2016

VU professor designs special apron for breast cancer patients

A Vanderbilt professor has designed a special apron for breast cancer patients after first-hand experience dealing with chest drainage tubes following surgery.
By Tom Wilemon
October 8, 2015

Komen, VICC partnership bolsters breast cancer research

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support.
By VUMC News and Communications
1 … 5 6 7 8 9 … 12